Background Cardiac surgery carries a heightened risk of bradyarrhythmias, but current permanent pacemaker (PPM) implantation ...
Introduction: Non-chemotherapy drug-induced agranulocytosis (NCDIA ... performed in strict accordance with the FDA’s official guidelines, as outlined in the flowchart in Supplementary Figure S1. To ...
This phenomenon is amplified through drug litigation, where interpretations of the right ... Court procedure selection flowchart. The demographic analysis revealed that 60.6% of patients were male, ...
Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...
| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how ...
GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...
Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...
The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...
The biopharmaceutical drug development process is expensive, and the biological ingredients are often in short supply. To mitigate long-term costs, it is helpful to be able to detect any ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement ...
Failure rates remain staggeringly high even with billions of dollars being invested in research and development (R&D). Between 70% and 90% of drug candidates will fail. This can be the result of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results